Listen for Gliptin Patients Complaining of Severe Joint Pain

October 2015

A new FDA warning will spur questions about whether gliptins (Januvia, Onglyza, etc) cause severe joint pain.

This risk seems to be a class effect of gliptins, and it's very rare...but the pain can be disabling.

We know these diabetes meds inhibit dipeptidyl peptidase-4 (DPP-4)...an enzyme that breaks down incretin hormones.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: PA includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote